Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease

Acta Neurologica Scandinavica

Volumn 127, Issue 5, 2013, Pages

  Zibetti, M ^a   Rizzone, M ^a   Merola, A ^a   Angrisano, S ^a   Rizzi, L ^a   Montanaro, E ^a   Cicolin, A ^a   Lopiano, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Excessive daytime sleepiness; Levodopa carbidopa intestinal gel infusion; Parkinson's disease; Sleep disorders

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CLOZAPINE; LEVODOPA; QUETIAPINE;

AGED; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; EPWORTH SLEEPINESS SCALE; FEMALE; GEL; HUMAN; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NIGHT SLEEP; NOTE; PARKINSON DISEASE; PARKINSON DISEASE SLEEP SCALE VERSION 2; PROSPECTIVE STUDY; SLEEP; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANTIPARKINSON AGENTS; CARBIDOPA; DISORDERS OF EXCESSIVE SOMNOLENCE; DRUG ADMINISTRATION ROUTES; DRUG COMBINATIONS; DUODENUM; FEMALE; GASTROSTOMY; GELS; HUMANS; INFUSION PUMPS, IMPLANTABLE; JEJUNUM; LEVODOPA; MALE; MIDDLE AGED; NOCTURNAL MYOCLONUS SYNDROME; PARKINSON DISEASE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS, INTRINSIC; TREATMENT OUTCOME;

EID: 84878361869     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12075     Document Type: Note

References (16)

1. Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson's disease therapeutics. Mov Disord 2011;26:1072-82.
2. ®) treatment for advanced Parkinson's disease: a review of efficacy and safety. Parkinsonism Relat Disord 2012;18:916-29.
3. Martinez-Martin P, Schapira A, Stocchi F et al. Prevalence of non-motor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22:1623-9.
4. Barone P, Antonini A, Colosimo C et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24:1641-9.
5. Honig H, Antonini A, Martinez-Martin P et al. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009;24:1468-74.
6. Martinez-Martin P, Gil-Nagel A, Gracia L, Gomez J, Martinez-Sarries J, Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
7. Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke C. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
8. Trenkwalder C, Kohnen R, Högl B et al. Parkinson disease sleep scale-Validation of the Revised Version PDSS-2. Mov Disord 2011;26:644-52.
9. Johns M. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
10. Ferreira J, Desboeuf K, Galitzky M et al. Sleep disruption, daytime somnolence and ''sleep attacks'' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol 2006;13:209-14.
11. Antonini A, Isaias I, Canesi M et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 2007;22:1145-9.
12. Puente V, De Fabregues O, Oliveras C et al. Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of life. Parkinsonism Relat Disord 2010;16:218-21.
13. Chaudhuri K, Pal S, Dimarco A et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-35.
14. Nyholm D, Jansson R, Willows T, Remahl I. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements. Neurology 2005;65:1506-7.
15. Bliwise D, Trotti L, Wilson A et al. Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class. Mov Disord 2012;27:1118-24.
16. Poryazova R, Benninger D, Waldvogel D, Bassetti C. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010;63:129-35.